<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moore C</submitter><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>Medical Research Council</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NIAMS NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>199-208</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6635791</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>200(2)</volume><pubmed_abstract>&lt;b>Rationale:&lt;/b> Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. &lt;b>Objectives:&lt;/b> To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. &lt;b>Methods:&lt;/b> We performed deep targeted resequencing (3.69 Mb of DNA) in cases (&lt;i>n&lt;/i> = 3,624) and control subjects (&lt;i>n&lt;/i> = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and &lt;i>1&lt;/i>) individual common variants via logistic regression and &lt;i>2&lt;/i>) groups of rare variants via sequence kernel association tests. &lt;b>Measurements and Main Results:&lt;/b> Statistically sign</pubmed_abstract><journal>American journal of respiratory and critical care medicine</journal><pubmed_title>Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.</pubmed_title><pmcid>PMC6635791</pmcid><funding_grant_id>U54 GM104938</funding_grant_id><funding_grant_id>R01 HL130796</funding_grant_id><funding_grant_id>K08 HL130595</funding_grant_id><funding_grant_id>P01 HL092870</funding_grant_id><funding_grant_id>R01 HL097163</funding_grant_id><funding_grant_id>U19 AI082714</funding_grant_id><funding_grant_id>T32 HL007085</funding_grant_id><funding_grant_id>P30 AR073750</funding_grant_id><funding_grant_id>UL1 RR024975</funding_grant_id><funding_grant_id>RP-2017-08-ST2-014</funding_grant_id><funding_grant_id>P30 AR053483</funding_grant_id><funding_grant_id>R33 HL120770</funding_grant_id><funding_grant_id>MR/N005953/1</funding_grant_id><pubmed_authors>Yang IV</pubmed_authors><pubmed_authors>Schwartz DA</pubmed_authors><pubmed_authors>Pardo A</pubmed_authors><pubmed_authors>Corte TJ</pubmed_authors><pubmed_authors>Miyazaki Y</pubmed_authors><pubmed_authors>Mathai SK</pubmed_authors><pubmed_authors>Bendstrup E</pubmed_authors><pubmed_authors>Kass DJ</pubmed_authors><pubmed_authors>Furusawa H</pubmed_authors><pubmed_authors>Brown KK</pubmed_authors><pubmed_authors>Poletti V</pubmed_authors><pubmed_authors>Rojas M</pubmed_authors><pubmed_authors>Armstong ME</pubmed_authors><pubmed_authors>Puppo F</pubmed_authors><pubmed_authors>Maher TM</pubmed_authors><pubmed_authors>Walker T</pubmed_authors><pubmed_authors>Russell P</pubmed_authors><pubmed_authors>Fingerlin TE</pubmed_authors><pubmed_authors>Isaksson HJ</pubmed_authors><pubmed_authors>Loyd JE</pubmed_authors><pubmed_authors>Schwarz MI</pubmed_authors><pubmed_authors>Ravaglia C</pubmed_authors><pubmed_authors>Inoue Y</pubmed_authors><pubmed_authors>Narumoto O</pubmed_authors><pubmed_authors>Kannengiesser C</pubmed_authors><pubmed_authors>Wilcox PG</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Lee J</pubmed_authors><pubmed_authors>Silverman EK</pubmed_authors><pubmed_authors>Tomassetti S</pubmed_authors><pubmed_authors>Gibson KF</pubmed_authors><pubmed_authors>Walts A</pubmed_authors><pubmed_authors>Borie R</pubmed_authors><pubmed_authors>Song JW</pubmed_authors><pubmed_authors>Maier LA</pubmed_authors><pubmed_authors>Kim DS</pubmed_authors><pubmed_authors>Sembrat J</pubmed_authors><pubmed_authors>de Andrade JA</pubmed_authors><pubmed_authors>Ma SF</pubmed_authors><pubmed_authors>Jenkins RG</pubmed_authors><pubmed_authors>Worboys AM</pubmed_authors><pubmed_authors>Molina-Molina M</pubmed_authors><pubmed_authors>Selman M</pubmed_authors><pubmed_authors>Baltic S</pubmed_authors><pubmed_authors>McElroy A</pubmed_authors><pubmed_authors>Luckhardt T</pubmed_authors><pubmed_authors>Prele C</pubmed_authors><pubmed_authors>Akagawa S</pubmed_authors><pubmed_authors>Patel NB</pubmed_authors><pubmed_authors>Bishop M</pubmed_authors><pubmed_authors>Ohta K</pubmed_authors><pubmed_authors>Beckman KB</pubmed_authors><pubmed_authors>Arai T</pubmed_authors><pubmed_authors>Moodley Y</pubmed_authors><pubmed_authors>Keane MP</pubmed_authors><pubmed_authors>Saini G</pubmed_authors><pubmed_authors>Donnelly SC</pubmed_authors><pubmed_authors>Strek ME</pubmed_authors><pubmed_authors>Okamoto T</pubmed_authors><pubmed_authors>Nathan SD</pubmed_authors><pubmed_authors>Hirose M</pubmed_authors><pubmed_authors>Markin CR</pubmed_authors><pubmed_authors>Porteous MK</pubmed_authors><pubmed_authors>Cardwell J</pubmed_authors><pubmed_authors>Pacheco KA</pubmed_authors><pubmed_authors>O'Riordan T</pubmed_authors><pubmed_authors>Saunders P</pubmed_authors><pubmed_authors>Laurent G</pubmed_authors><pubmed_authors>Suzukawa M</pubmed_authors><pubmed_authors>Rassl D</pubmed_authors><pubmed_authors>Noth I</pubmed_authors><pubmed_authors>Henry MT</pubmed_authors><pubmed_authors>Kreider ME</pubmed_authors><pubmed_authors>Cogan JD</pubmed_authors><pubmed_authors>Sundy JS</pubmed_authors><pubmed_authors>James JA</pubmed_authors><pubmed_authors>Braybrooke R</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Montesi SB</pubmed_authors><pubmed_authors>Kulkarni T</pubmed_authors><pubmed_authors>Molyneaux PL</pubmed_authors><pubmed_authors>Cho MH</pubmed_authors><pubmed_authors>Vestal B</pubmed_authors><pubmed_authors>Crestani B</pubmed_authors><pubmed_authors>Machahua C</pubmed_authors><pubmed_authors>Wolters PJ</pubmed_authors><pubmed_authors>Podolanczuk AJ</pubmed_authors><pubmed_authors>Doran P</pubmed_authors><pubmed_authors>Bair C</pubmed_authors><pubmed_authors>Gudmundsson G</pubmed_authors><pubmed_authors>Swigris JJ</pubmed_authors><pubmed_authors>Mogulkoc N</pubmed_authors><pubmed_authors>Sterclova M</pubmed_authors><pubmed_authors>Guthridge JM</pubmed_authors><pubmed_authors>Kokturk N</pubmed_authors><pubmed_authors>Ryerson CJ</pubmed_authors><pubmed_authors>Venuto DC</pubmed_authors><pubmed_authors>Crapo JD</pubmed_authors><pubmed_authors>Bonella F</pubmed_authors><pubmed_authors>Parfrey H</pubmed_authors><pubmed_authors>Shea BS</pubmed_authors><pubmed_authors>Eickelberg O</pubmed_authors><pubmed_authors>Fernandez IE</pubmed_authors><pubmed_authors>Powers J</pubmed_authors><pubmed_authors>Blumhagen RZ</pubmed_authors><pubmed_authors>Kropski JA</pubmed_authors><pubmed_authors>Lederer DJ</pubmed_authors><pubmed_authors>Carbone RG</pubmed_authors><pubmed_authors>Aranda A</pubmed_authors><pubmed_authors>Hirani N</pubmed_authors><pubmed_authors>Nickerson DA</pubmed_authors><pubmed_authors>Steele MP</pubmed_authors><pubmed_authors>Glaspole I</pubmed_authors><pubmed_authors>Vasakova M</pubmed_authors><pubmed_authors>Woldehanna ML</pubmed_authors><pubmed_authors>Ji W</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Danchel V</pubmed_authors><pubmed_authors>Behr J</pubmed_authors><pubmed_authors>Moore C</pubmed_authors><pubmed_authors>Collard HR</pubmed_authors><pubmed_authors>Fiddler C</pubmed_authors><pubmed_authors>Poon AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.</name><description>&lt;b>Rationale:&lt;/b> Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. &lt;b>Objectives:&lt;/b> To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. &lt;b>Methods:&lt;/b> We performed deep targeted resequencing (3.69 Mb of DNA) in cases (&lt;i>n&lt;/i> = 3,624) and control subjects (&lt;i>n&lt;/i> = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and &lt;i>1&lt;/i>) individual common variants via logistic regression and &lt;i>2&lt;/i>) groups of rare variants via sequence kernel association tests. &lt;b>Measurements and Main Results:&lt;/b> Statistically sign</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2025-06-01T02:35:51.208Z</modification><creation>2025-06-01T02:35:51.208Z</creation></dates><accession>S-EPMC6635791</accession><cross_references><pubmed>31034279</pubmed><doi>10.1164/rccm.201810-1891OC</doi><doi>10.1164/rccm.201810-1891oc</doi></cross_references></HashMap>